NO20084863L - "Insulinotropic" peptidsyntese - Google Patents

"Insulinotropic" peptidsyntese

Info

Publication number
NO20084863L
NO20084863L NO20084863A NO20084863A NO20084863L NO 20084863 L NO20084863 L NO 20084863L NO 20084863 A NO20084863 A NO 20084863A NO 20084863 A NO20084863 A NO 20084863A NO 20084863 L NO20084863 L NO 20084863L
Authority
NO
Norway
Prior art keywords
fragments
phase
solid
solution
insulinotropic
Prior art date
Application number
NO20084863A
Other languages
English (en)
Norwegian (no)
Inventor
Christopher R Roberts
Lin Chen
Yeun-Kwei Han
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20084863L publication Critical patent/NO20084863L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20084863A 2006-06-23 2008-11-19 "Insulinotropic" peptidsyntese NO20084863L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81591906P 2006-06-23 2006-06-23
PCT/EP2007/056052 WO2007147816A1 (fr) 2006-06-23 2007-06-19 Synthèse de peptides insulinotropes

Publications (1)

Publication Number Publication Date
NO20084863L true NO20084863L (no) 2009-01-22

Family

ID=38596729

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084863A NO20084863L (no) 2006-06-23 2008-11-19 "Insulinotropic" peptidsyntese

Country Status (33)

Country Link
US (2) US20080004429A1 (fr)
EP (1) EP2035451B1 (fr)
JP (1) JP4537495B2 (fr)
KR (1) KR101087859B1 (fr)
CN (1) CN101563364B (fr)
AR (1) AR061604A1 (fr)
AT (1) ATE466881T1 (fr)
AU (1) AU2007263043B2 (fr)
BR (1) BRPI0713575A2 (fr)
CA (1) CA2654610C (fr)
CL (1) CL2007001835A1 (fr)
CR (1) CR10463A (fr)
CY (1) CY1110186T1 (fr)
DE (1) DE602007006310D1 (fr)
DK (1) DK2035451T3 (fr)
EC (1) ECSP088999A (fr)
ES (1) ES2341588T3 (fr)
HR (1) HRP20100302T1 (fr)
IL (1) IL195421A0 (fr)
MA (1) MA30530B1 (fr)
MX (1) MX2008015935A (fr)
MY (1) MY144608A (fr)
NO (1) NO20084863L (fr)
NZ (1) NZ573093A (fr)
PL (1) PL2035451T3 (fr)
PT (1) PT2035451E (fr)
RS (1) RS51281B (fr)
RU (1) RU2448978C2 (fr)
SI (1) SI2035451T1 (fr)
TW (1) TWI331155B (fr)
UA (1) UA96602C2 (fr)
WO (1) WO2007147816A1 (fr)
ZA (1) ZA200810072B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101835794A (zh) 2007-10-27 2010-09-15 霍夫曼-拉罗奇有限公司 使用固相和溶液相组合技术的促胰岛素肽合成法
AU2008334783A1 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
US20100317057A1 (en) 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
US20100183876A1 (en) * 2008-12-23 2010-07-22 Hell Andre Process for the Preparation of a Peptide Powder Form
JP2012525348A (ja) * 2009-05-01 2012-10-22 エフ．ホフマン−ラ ロシュ アーゲー 固相及び溶液相の組み合わせ技術を用いたインスリン分泌促進ペプチド合成
US20110313131A1 (en) * 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
DK2788110T3 (en) * 2011-12-08 2019-02-11 Pentair Water Pool & Spa Inc AQUACULTURE SYSTEM AND PROCEDURE TO OPERATE A PUMP IN SUCH A SYSTEM
WO2013098191A1 (fr) * 2011-12-29 2013-07-04 Novo Nordisk A/S Dipeptide comprenant un acide aminé non protéogénique
WO2014077801A1 (fr) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Procédé de purification pour préparer du tasoglutide de haute pureté
CN104936610A (zh) 2012-11-13 2015-09-23 益普生制药股份有限公司 Glp-1类似物的纯化方法
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
CN111819191B (zh) * 2018-03-09 2024-08-20 费森尤斯卡比有限公司 利拉鲁肽、索马鲁肽和glp-1的化学酶促合成
EP3762408A1 (fr) 2018-03-09 2021-01-13 Enzypep B.V. Synthèse chimio-enzymatique de semaglutide, de liraglutide et de glp-1
US11396533B2 (en) 2018-10-09 2022-07-26 Fresenius Kabi Ipsum S.R.L. Process for the manufacture of GLP-1 analogues
TWI738260B (zh) * 2019-03-25 2021-09-01 台灣神隆股份有限公司 純化利拉魯肽之方法
WO2020254479A1 (fr) * 2019-06-18 2020-12-24 Fresenius Kabi Ipsum S.R.L. Procédé de fabrication de glucagon
EP3753946A1 (fr) 2019-06-18 2020-12-23 Fresenius Kabi iPSUM S.r.l. Procédé amélioré pour la préparation de glucagon à pureté élevée
US20230406900A1 (en) * 2022-06-01 2023-12-21 Scinopharm Taiwan, Ltd. Process for preparing glucagon-like peptide-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
AU5441096A (en) * 1995-04-14 1996-10-30 The Administrators Of The Tulane Eductional Fund Analogs of growth hormone-releasing factor
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
CZ295768B6 (cs) * 1998-12-07 2005-10-12 Societe De Conseils De Recherches Et D'application Analogy GLP-1, mající beta-alanin na pozici 35, jejich použití a farmaceutické prostředky je obsahující
US6514500B1 (en) * 1999-10-15 2003-02-04 Conjuchem, Inc. Long lasting synthetic glucagon like peptide {GLP-!}
US7238671B2 (en) 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
EP1701970A2 (fr) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Procedes pour recuperer un peptide clive a partir d'un support

Also Published As

Publication number Publication date
KR20090023619A (ko) 2009-03-05
ZA200810072B (en) 2009-12-30
ECSP088999A (es) 2009-01-30
RU2009101969A (ru) 2010-07-27
CN101563364A (zh) 2009-10-21
CY1110186T1 (el) 2015-01-14
MY144608A (en) 2011-10-14
NZ573093A (en) 2012-01-12
KR101087859B1 (ko) 2011-11-30
PT2035451E (pt) 2010-06-09
CA2654610C (fr) 2012-03-20
MX2008015935A (es) 2009-01-13
JP2009541257A (ja) 2009-11-26
WO2007147816A1 (fr) 2007-12-27
ES2341588T3 (es) 2010-06-22
UA96602C2 (ru) 2011-11-25
CL2007001835A1 (es) 2008-03-14
RS51281B (sr) 2010-12-31
BRPI0713575A2 (pt) 2013-02-13
CA2654610A1 (fr) 2007-12-27
AU2007263043A1 (en) 2007-12-27
JP4537495B2 (ja) 2010-09-01
IL195421A0 (en) 2011-08-01
CR10463A (es) 2009-02-26
AU2007263043B2 (en) 2012-11-29
AR061604A1 (es) 2008-09-10
SI2035451T1 (sl) 2010-06-30
EP2035451A1 (fr) 2009-03-18
MA30530B1 (fr) 2009-06-01
DE602007006310D1 (fr) 2010-06-17
ATE466881T1 (de) 2010-05-15
CN101563364B (zh) 2014-04-02
TW200811195A (en) 2008-03-01
RU2448978C2 (ru) 2012-04-27
TWI331155B (en) 2010-10-01
DK2035451T3 (da) 2010-06-07
US20080004429A1 (en) 2008-01-03
EP2035451B1 (fr) 2010-05-05
PL2035451T3 (pl) 2010-08-31
US20110213082A1 (en) 2011-09-01
HRP20100302T1 (hr) 2010-06-30

Similar Documents

Publication Publication Date Title
NO20084863L (no) "Insulinotropic" peptidsyntese
MX2010006044A (es) Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion.
RU2559320C2 (ru) Новые аналоги глюкагона
TWI666026B (zh) Ｗｔ１抗原胜肽結合疫苗
Patil et al. Relaxin family peptides: structure–activity relationship studies
Burlina et al. In situ thioester formation for protein ligation using α-methylcysteine
KR102461744B1 (ko) 아미노 2산을 함유한 펩타이드 변형제
TW201639867A (zh) 胜肽合成方法
EP1958957A1 (fr) Polypeptide comprenant un partie caractéristique des protéines appellées "Knottins"
TW201348252A (zh) Ｇｉｐ－ｇｌｐ－１雙重促效劑化合物及方法
PE20060816A1 (es) Proceso para la concentracion de anticuerpos y productos terapeuticos de los mismos
Fukuzumi et al. Chemoselective cyclization of unprotected linear peptides by α-ketoacid–hydroxylamine amide-ligation
JP2003508350A (ja) 血液成分への結合体化を介するペプチダーゼ活性からの内因性治療用ペプチドの保護
Raz et al. HF‐free Boc synthesis of peptide thioesters for ligation and cyclization
US20200317721A1 (en) A process for preparing a glucagon-like peptide
JP2013540793A (ja) デガレリクスおよびその中間体を製造する方法
WO2010125079A3 (fr) Synthèse de peptides insulinotropiques à l'aide d'une combinaison de techniques en phase solide et soluble
JP2015523373A (ja) ｅＩＦ４Ｅを標的化するための細胞浸透性ペプチド
Monsó et al. Reverse thioether ligation route to multimeric peptide antigens
TW201012829A (en) Process for the synthesis of (Aib8,35)hGLP-1(7-36)-NH2
TWI300414B (en) Modified peptide yy and conjugates thereof
Conroy et al. Efficient use of the Dmab protecting group: applications for the solid-phase synthesis of N-linked glycopeptides
Dong et al. Toward Homogeneous Erythropoietin: Application of Metal‐Free Dethiylation in the Chemical Synthesis of the Ala79‐Arg166 Glycopeptide Domain
WO2007100358A3 (fr) Synthèse convergente de protéines par ligature à cinétique contrôlée
US10239914B2 (en) In-situ solvent recycling process for solid phase peptide synthesis at elevated temperatures

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application